What is Spravato?

Spravato® is a prescription nasal spray that contains esketamine, a medication derived from ketamine used to treat certain forms of severe depression. Unlike traditional antidepressants that mainly affect serotonin and may take weeks to work, esketamine targets different brain receptors involved in mood regulation and neural communication. By acting on these pathways, Spravato® helps improve brain signaling and may provide relief for individuals who have not responded to standard antidepressant medications.

This treatment is approved for adults living with treatment-resistant depression or major depressive disorder with suicidal thoughts, particularly when other therapies have not been effective. Because of its specialized nature, Spravato® is administered only in a certified medical setting under professional supervision, where patients are monitored during each treatment session.

FDA-Approved Spravato Treatment in Dallas

How SPRAVATO® Works in the Brain

Understanding how esketamine interacts with brain chemistry to provide rapid relief for treatment-resistant depression.

01

Targets Different Brain Receptors

Spravato® targets NMDA receptors in the brain involved in mood regulation, working differently from traditional antidepressants.

02

Activates the Glutamate System

Spravato® helps increase glutamate activity, an important brain chemical that supports communication between nerve cells.

03

Supports New Neural Connections

Glutamate activity encourages the brain to form new neural connections, restoring healthier mood and emotional balance.

04

Improves Depression Symptoms

By strengthening brain pathways, Spravato® may reduce symptoms of treatment-resistant depression rapidly.

Who Can Benefit From Spravato?

Spravato® may benefit adults who continue to experience depression even after trying standard antidepressant medications. This treatment offers an alternative approach for individuals seeking advanced care for severe or persistent depressive symptoms.People who may benefit from Spravato® therapy include:

  • Adults with Treatment-Resistant Depression (TRD) who have not responded to multiple antidepressants.
  • Individuals diagnosed with Major Depressive Disorder (MDD) with ongoing symptoms.
  • Patients who may need a faster-acting treatment option than traditional medications.
  • Adults experiencing depression with suicidal thoughts who require monitored clinical care.
  • Individuals whose depression continues to affect daily life and overall well-being.
SPRAVATO Treatment

What to Expect During SPRAVATO Treatment

01

Comprehensive Evaluation

A clinician reviews your medical history, current medications, and prior treatments to determine whether SPRAVATO is appropriate for you.

02

Insurance Verification

Our staff reviews your insurance benefits and explores financial assistance options if needed.

03

Initial Treatment Phase

Patients typically receive SPRAVATO twice weekly for the first four weeks while being monitored in the clinic.

04

Observation Period

Each visit includes approximately two hours of post-treatment monitoring to ensure safety.

05

Maintenance Treatment

Once improvement is achieved, the frequency of treatments is gradually reduced based on your individualized care plan.

Am I a Candidate for Spravato®?

Spravato® therapy may be an option for adults who continue to struggle with depression despite trying traditional treatments. If standard antidepressants have not provided enough relief, this treatment may help address symptoms through a different brain pathway. A psychiatric evaluation is usually required to determine if Spravato® is an appropriate option for your condition.You may be a candidate for Spravato® treatment if you:

  • Are 18 years or older and diagnosed with Major Depressive Disorder (MDD)
  • Have tried two or more antidepressants without significant improvement
  • Are currently taking an oral antidepressant alongside Spravato®
  • Experience persistent depressive symptoms or suicidal thoughts requiring advanced care
Woman reading by window

Contact Our Office to Learn More About Spravato

Spravato treatment in Richardson at Premier Pain Centers & Premier Psychiatry offers a new path forward for individuals struggling with treatment-resistant depression. This advanced therapy works differently from traditional medications and is administered under careful medical supervision for patient safety and comfort. Take the next step toward better mental health by connecting with our team today.

Schedule an appointment with Premier Pain Centers & Premier Psychiatry today and start your journey toward renewed mental wellness.

469-562-4188Book Appointment →
✓ HIPAA-Compliant Platform✓ All Major Insurance Accepted

FAQ's

The Answers to Your Questions

Contact Us Today
Spravato® is available only through a restricted safety program called the Spravato® Risk Evaluation and Mitigation Strategy (REMS). This program ensures the medication is administered only in certified healthcare settings under medical supervision to monitor for possible side effects such as sedation or dissociation.
Spravato® is given as a nasal spray in a certified medical clinic under the supervision of a healthcare provider. Patients self-administer the spray while the medical team monitors them during and after treatment.
After taking Spravato®, patients are observed by medical staff for at least two hours to monitor their response and ensure they are safe before leaving the clinic.
No. Patients should not drive or operate machinery after treatment. A family member or caregiver must drive you home after each Spravato® session.
Yes. Patients are usually advised not to eat for at least 2 hours before treatment and avoid drinking liquids for at least 30 minutes before the session to reduce the risk of nausea or vomiting.
Spravato® may not be suitable for individuals who have certain blood vessel conditions, a history of brain bleeding, or allergies to esketamine or ketamine. A healthcare provider will evaluate your medical history before starting treatment.
No. Spravato® is approved only for adults (18+) and is not recommended for children or teenagers.
If you miss a treatment session, your healthcare provider may adjust your treatment schedule or dosage to keep your therapy effective.